Profile
A.
Keith Willard served as Chairman & CEO at Zeneca, Inc. from 1999 to 1999.
He was President & Director at ICI Canada, Inc. from 1993 to 1999.
He also served as an Independent Director at Inhibitex LLC from 2011 to 2012.
Willard received his undergraduate degree from McGill University and another undergraduate degree from Concordia University.
Former positions of A. Keith Willard
Companies | Position | End |
---|---|---|
Inhibitex LLC
Inhibitex LLC Pharmaceuticals: MajorHealth Technology Inhibitex, Inc. operates as an clinical-stage biopharmaceutical company. The firm develops differentiated anti-infective products to prevent or treat serious infections. Its research and development efforts are currently focused on oral, small molecule compounds to treat viral infections, and in particular, chronic infections caused by HCV and herpes zoster. The company was founded by Joseph M. Patti in May 1994 and is headquartered in Alpharetta, GA. | Director/Board Member | 12/02/2012 |
ICI Canada, Inc. | President | 30/09/1999 |
Zeneca, Inc. | Chairman | 31/12/1998 |
Training of A. Keith Willard
Concordia University | Undergraduate Degree |
McGill University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 3 |
---|---|
Inhibitex LLC
Inhibitex LLC Pharmaceuticals: MajorHealth Technology Inhibitex, Inc. operates as an clinical-stage biopharmaceutical company. The firm develops differentiated anti-infective products to prevent or treat serious infections. Its research and development efforts are currently focused on oral, small molecule compounds to treat viral infections, and in particular, chronic infections caused by HCV and herpes zoster. The company was founded by Joseph M. Patti in May 1994 and is headquartered in Alpharetta, GA. | Health Technology |
ICI Canada, Inc. | |
Zeneca, Inc. |
- Stock Market
- Insiders
- A. Keith Willard